易瑞生物控股股东方3个月套现1亿元 此前已套现1.25亿

Core Viewpoint - The announcement details the share reduction plan of the controlling shareholder and its concerted actions, indicating a significant divestment of shares from the company. Group 1: Share Reduction Plan - The controlling shareholder, EasyRui (Hainan) Venture Capital Co., Ltd. (EasyRui Venture), plans to reduce its holdings by up to 11,521,758 shares, representing 2.84% of the total share capital [1] - The shareholder EasyDaiRui plans to reduce its holdings by up to 288,500 shares, representing 0.07% of the total share capital [1] - The shareholder EasyKaiRui plans to reduce its holdings by up to 341,800 shares, representing 0.08% of the total share capital [2] Group 2: Reduction Results - From November 12, 2025, to January 29, 2026, the total shares reduced by the controlling shareholder and its concerted actions amounted to 10,680,200 shares, which is 2.6366% of the total share capital [2] - The average reduction price ranged from 8.81 yuan/share to 9.85 yuan/share [2] - The total cash generated from this reduction is approximately 99 million yuan [3] Group 3: Previous Reductions - EasyRui Venture and the actual controller Zhu Hai previously reduced their holdings from July 28 to September 5, 2025, with a total amount of 1.25 billion yuan [4] - The reductions included various transactions, with average prices of 10.66 yuan/share and 12.96 yuan/share for different periods [4]

Shenzhen Bioeasy Biotechnology -易瑞生物控股股东方3个月套现1亿元 此前已套现1.25亿 - Reportify